MedTrace Logo

Short-term and Intermediate-term Effects of Self-applied Joint Mobilization Versus Clinician-applied Joint Mobilization in Addition to Exercise in Patients With Knee Osteoarthritis: A Randomized Clinical Trial

NCT07020897 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-06-13

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a combination of patient self-administered joint mobilization and exercise works to treat knee osteoarthritis in adults. The main questions it aims to answer are:

* Does self-administered joint mobilization improve the ability to perform regular daily activities?
* Does self-administered joint mobilization improve knee motion?
* Does self-administered joint mobilization improve hip strength?

Researchers will compare the program of self-administered joint mobilization to a joint mobilization administered by a physical therapist.

Participants will:

* Attend 8-12 physical therapy clinic visits over 6 - 8 weeks
* Perform home exercises
* Visit the clinic 6 months later for a brief check-up

Conditions

Interventions

OTHER

Clinician-administered joint mobilization

Tibiofemoral arthrokinematic extension joint mobilization and multidirectional patellofemoral mobilization applied by a physical therapist.

OTHER

Self-administered joint mobilization

Tibiofemoral arthrokinematic extension joint mobilization and multidirectional patellofemoral mobilization applied by the research participant.

OTHER

Exercise-based physical therapy

In-clinic exercise-based physical therapy supervised by a physical therapist, with home exercises to be performed on days without a clinical visit.

Sponsors & Collaborators

  • Texas Health Resources

    collaborator OTHER

  • Texas Woman's University

    lead OTHER

Principal Investigators

  • Guy L Terry, MPT, PhD(c) · Texas Woman's University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-15
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07020897 on ClinicalTrials.gov